HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Radionuclide evaluation of renal artery dilatation.

Abstract
Radionuclide studies were sued in three patients to evaluate renal perfusion and function within 24 hours following transluminal dilatation. In one patient, technetium-99 m pertechnetate showed good renal perfusion one and 12 hours after a post-dilatation arteriogram had shown a renal artery intimal defect. Improved clearance of iodine-131 ortho-iodohippurate from the blood demonstrated an increase in renal function 18 hours following dilatation of a stenosis at a renal allograft anastomosis in the second patient, while technetium-99 m-labeled DTPA showed an improved total glomerular filtration rate 24-hours after dilatation of a saphenous vein bypass graft in the third patient. It was concluded that renal radionuclide studies are of benefit in evaluating patients in the immediate post-dilatation period.
AuthorsM L Born, A J Gerlock Jr, V Goncharenko, J W Hollifield, R C MacDonell Jr
JournalCardiovascular and interventional radiology (Cardiovasc Intervent Radiol) Vol. 4 Issue 3 Pg. 177-82 ( 1981) ISSN: 0174-1551 [Print] United States
PMID6269740 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Iodine Radioisotopes
  • Technetium
  • Pentetic Acid
  • Sodium Pertechnetate Tc 99m
  • Technetium Tc 99m Pentetate
Topics
  • Adult
  • Aged
  • Angioplasty, Balloon
  • Evaluation Studies as Topic
  • Female
  • Glomerular Filtration Rate
  • Humans
  • Iodine Radioisotopes
  • Male
  • Middle Aged
  • Pentetic Acid
  • Radionuclide Imaging
  • Renal Artery Obstruction (diagnostic imaging, therapy)
  • Sodium Pertechnetate Tc 99m
  • Technetium
  • Technetium Tc 99m Pentetate

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: